COMMUNIQUÉS West-GlobeNewswire

Foamix Reports Third Quarter 2018 Financial Results and Provides Corporate Update

07/11/2018 - 22:05

Conference Call and Webcast Thursday, November 8, @ 8.30 am Eastern Time REHOVOT, Israel, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX) (“Foamix” or the “Company”), a clinical stage [...]

Zafgen Reports Third Quarter 2018 Operating and Financial Results

07/11/2018 - 22:05

ZGN-1061 1.8 mg cohort for the Phase 2 proof-of-concept trial now fully enrolled; on track for topline results early 2019 ZGN-1258 nonclinical safety and efficacy data sets presented at Foundation for Prader-Willi [...]

Codexis to Present at Two Investment Conferences in November

07/11/2018 - 22:05

REDWOOD CITY, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that management will present at two upcoming investment conferences: 9 th Annual [...]

Axovant Announces Second Fiscal Quarter 2018 Financial Results and Corporate Updates

07/11/2018 - 22:05

First patient dosed in clinical study of AXO-Lenti-PD, a novel gene therapy for treatment of Parkinson’s disease Expanded pipeline of gene therapies with in-licensing of AXO-AAV-OPMD for treatment of oculopharyngeal [...]

Opiant Pharmaceuticals, Inc. Reports Third Quarter 2018 Financial Results and Provides Corporate Update

07/11/2018 - 22:05

SANTA MONICA, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions and drug overdose, [...]

MediWound to Host Third Quarter 2018 Financial Results Conference Call on November 13 at 8:30 a.m. Eastern Time

07/11/2018 - 22:05

YAVNE, Israel, Nov. 07, 2018 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, [...]

Calithera Biosciences Reports Third Quarter 2018 Financial Results and Recent Highlights

07/11/2018 - 22:05

-Calithera to Host Conference Call Today at 2:00 p.m. Pacific Time/ 5:00 p.m. Eastern Time SOUTH SAN FRANCISCO, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage [...]

Menlo Therapeutics Reports Third Quarter 2018 Financial Results and Provides Business Update

07/11/2018 - 22:05

~ Phase 2 Data in Psoriasis Expected December 2018 ~ ~ New Phase 2 Clinical Trial in Chronic Pruritus of Unknown Origin Expected to Start in Q4 2018 ~ ~ Prurigo Nodularis Phase 3 Clinical Trials Enrolling in U.S. and [...]

Portola Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update

07/11/2018 - 22:05

– Third Quarter Andexxa Product Revenues of $7.7 Million – – Company Improves Financial Expectations for 2018 Operating Expenses – – Conference Call Today at 4:30 p.m. ET – SOUTH SAN FRANCISCO, Calif., Nov. 07, 2018 ( [...]

Wright Medical Group N.V. Reports 2018 Third Quarter Financial Results

07/11/2018 - 22:05

Third Quarter 2018 Net Sales of $194 Million, 13.8% as Reported Growth and 14.4% Constant Currency Growth Third Quarter 2018 Net Loss From Continuing Operations of $36 Million; Non-GAAP Adjusted EBITDA From Continuing [...]

Immunomedics Announces First Quarter Fiscal 2019 Results and Provides Corporate Update

07/11/2018 - 22:05

Strategic Manufacturing Partnership Entered into with Samsung BioLogics to Provide Anticipated Long-Term Supply of Sacituzumab Govitecan Commercial Launch Preparations Nearing Completion with 50 Sales Representatives [...]

GenMark Diagnostics to Present at Upcoming Investor Conferences

07/11/2018 - 22:05

CARLSBAD, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced the company plans to [...]

Novavax Reports Third Quarter 2018 Financial Results

07/11/2018 - 22:05

Company to Host Conference Call Today at 4:30 p.m. ET GAITHERSBURG, Md., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq: NVAX) today announced its financial results and operational highlights for the third [...]

Spine Injury Solutions Schedules Third Quarter Fiscal Year 2018 Conference Call for November 13, 2018 at 11:00 a.m. EST

07/11/2018 - 22:04

HOUSTON, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Spine Injury Solutions, Inc. (OTCQB:SPIN), will hold an investor conference call on Tuesday, November 13, at 11:00 am (EST) to discuss its financial results for Q3 Fiscal Year [...]

Xenon Pharmaceuticals to Present at the Stifel 2018 Healthcare Conference

07/11/2018 - 22:02

BURNABY, British Columbia, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that Dr. Simon Pimstone, Xenon's Chief Executive Officer [...]

Ziopharm Oncology to Present at the Stifel 2018 Healthcare Conference on Nov. 14

07/11/2018 - 22:02

BOSTON, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq: ZIOP), today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer, will present at the Stifel 2018 Healthcare Conference in New [...]

TRACON Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update

07/11/2018 - 22:02

SAN DIEGO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer [...]

miRagen Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update

07/11/2018 - 22:01

Continued advancements of three clinical stage microRNA-targeted product candidates currently being evaluated for multiple potential indications in four clinical trials Global Phase 2 SOLAR clinical trial of cobomarsen [...]

TearLab Corporation Reports Third Quarter 2018 Financial Results

07/11/2018 - 22:01

ESCONDIDO, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB: TEAR) (“TearLab” or the “Company”) today reported its consolidated financial results for the third quarter ended September 30, 2018. All [...]